Aptus Capital Advisors, LLC Royalty Pharma PLC Transaction History
Aptus Capital Advisors, LLC
- $12.7 Billion
- Q3 2025
A detailed history of Aptus Capital Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 14,083 shares of RPRX stock, worth $551,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,083
Previous 10,714
31.44%
Holding current value
$551,490
Previous $386,000
28.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
535Shares Held
303MCall Options Held
1.34MPut Options Held
252K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.07 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$478 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...